Fusion polypeptides capable of activating receptors

Details for Australian Patent Application No. 2005206536 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Chen, Gang; Fandl, James; Papadopoulos, Nicholas; Aldrich, Thomas H.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005206536

PCT Pub. Number WO2005/070966

Priority 60/536,968 16.01.04 US

Filing date 14 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 2 September 2010

International Classifications

C07K 14/515 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/070966 Priority application(s): WO2005/070966

2 September 2010 Application Accepted

  Published as AU-B-2005206536

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206540-Antidiabetic oxazolidinediones and thiazolidinediones

2005206524-Substituted diazabicycloheptanes and their use as protein kinase inhibitors